Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-24

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved the original application for olmesartan medoxomil, a generic antihypertensive medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)